Clin2
NCT06662773Possibly a fitNot yet recruiting

Study of TQB3616 drug interactions in healthy volunteers

Healthy

This study tests how a new drug called TQB3616 interacts with other medicines. It is for healthy volunteers aged 18 to 45 to help understand how the drug is processed in the body.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • Be between 18 and 45 years old
  • Weigh at least 50 kg (men) or 45 kg (women) with a healthy body mass index (BMI) between 19 and 26
  • Be in good general health with no serious medical conditions, allergies, or recent infections
  • Not smoke more than 5 cigarettes a day, drink alcohol heavily, or use recreational drugs
  • Agree to avoid certain foods, drinks, and medications during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07685600Recruiting· Phase 1
Drug interaction study of AZD4144 and itraconazole

This trial checks if a new drug (AZD4144) works differently when taken with an antifungal medicine (itraconazole) in healthy volunteers. It helps doctors understand how to adjust doses for people who need both medicines.

Harrow
NCT06492525Not yet recruiting· Phase 1
Study of ensartinib with rifampicin or itraconazole in healthy volunteers

This trial tests how a drug called ensartinib interacts with two common medications (rifampicin and itraconazole) in healthy volunteers. It helps doctors understand how to adjust doses for future patients.

Hangzhou, Zhejiang
NCT07438886Not yet recruiting· Phase 1
How Catequentinib Interacts with Other Drugs in Healthy Volunteers

This study tests how a new anti-cancer drug called catequentinib (AL3818) interacts with other medicines in healthy people. It helps researchers understand how the drug is processed in the body.

Beijing, Beijing Municipality
NCT07482592Recruiting· Phase 1
Study of TQB3205 for advanced solid tumors

This trial tests an experimental drug called TQB3205 for people with advanced solid tumors that have not responded to other treatments. The study will check if the drug is safe and how it affects the tumors.

Tianjin, Tianjin Municipality
NCT07374224Recruiting· Phase 1
Testing how other drugs affect a new leukemia tablet

This study looks at how two common medicines, itraconazole and rifampin, change the levels of a new drug called Rocbrutinib in healthy volunteers. The results will help doctors understand how to use Rocbrutinib safely in future patients.

Beijing, Beijing Municipality
NCT07134465Enrolling by invitation· Phase 1
Drug interaction study of HSK31858 and itraconazole

This study checks if itraconazole changes how the body processes HSK31858. Healthy volunteers are needed to help understand the safety and drug levels.

Shanghai

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.